Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRevolution Beauty Regulatory News (REVB)

Share Price Information for Revolution Beauty (REVB)

Share Price is delayed by 15 minutes
Get Live Data
4.59    -0.06 (-1.29%)
Bid:
4.44
Ask:
4.63
Spread: 0.19 (4.279%)
Market Cap: £39.92m
REVB Live PriceLast checked at - London Stock Exchange

Intraday Revolution Beauty Share Chart

Appointment of CEO

28 Nov 2022 07:00

RNS Number : 7018H
Revolution Beauty Group PLC
28 November 2022
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

For Immediate Release

28 November 2022

 

 

 

 

REVOLUTION BEAUTY GROUP PLC

("Revolution Beauty", the "Group" or the "Company")

 

Appointment of CEO

Revolution Beauty Group plc (AIM: REVB), the multi-channel mass beauty innovator, is pleased to announce the appointment of Bob Holt OBE as Chief Executive Officer (CEO). Bob has been providing leadership to the business as interim Chief Operating Officer since 14 October 2022, and will become CEO with immediate effect.

Bob is an accomplished executive with more than 30 years' experience in senior positions and executive roles across a wide range of sectors. Having led as CEO and Executive Chairman a number of UK listed companies, including the turnaround of SureServe Group Plc and significant growth of Mears Group Plc, the Board believe he is the right person to drive the business forward.

The independent investigation being carried out by Forensic Risk Alliance and Macfarlanes remains ongoing, and no conclusions have been drawn. An update will be released to the market in due course.

Bob holds no shares in the Company.

Bob Holt, Incoming CEO of Revolution Beauty said: "Over the past six weeks I have seen first-hand the quality of people working at Revolution Beauty, the overall popularity of the brand and innovation of products for customers around the world. I believe there is a huge opportunity for the business as it moves ahead and I am confident that, together with the team, we will drive the business forward."

Information on Bob required to be disclosed under Schedule Two, paragraph (g) (i)-(viii) of the AIM Rules for Companies:

Robert ("Bob") Holt, aged 68, currently holds directorships and partnerships in the following companies:

Business Strategy LLP

Coal Hole Limited

Global Trees

Leadership Today Limited

The Logical Utilities Company Limited

Totally Plc

 

In addition, Bob has held the following directorships in the past five years:

Arbed Am Byth Limited

DX (Group) Plc 

Ensco 996 Limited

Ensco 997 Limited

Inprova Group Ltd

Mears Group Plc

Seneca Partners Limited

Senone LLP

Sureserve Compliance Services Limited

Sureserve Design & Build Limited

Sureserve Energy Services Limited

Sureserve Group Plc

Sureserve Holdings Limited

Sureserve Vgs Limited 

The Mears Foundation

 

 

For further information please contact:

Revolution Beauty Group plc

 

Bob Holt / Elizabeth Lake

Investor.Relations@revolutionbeautyplc.com

 

Joint Corporate Brokers

 

 

Zeus (NOMAD): Nick Cowles /Jamie Peel /Jordan Warburton 

Liberum: Clayton Bush / Edward Thomas / Miquela Bezuidenhoudt

 

Tel: +44 (0) 161 831 1512

 

Tel: +44 (0) 203 100 2222

 

 

Media enquiries:

Headland Consultancy

Rosh Field / Will Smith / Marta Parry-Jones

 

Tel: +44 (0)7872 350428

Tel: +44 (0)7884 742400

Revolutionbeauty@headlandconsultancy.com

 

- Ends -

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGRWGUPPPPM
Date   Source Headline
8th Jun 20267:00 amRNSNew Licensing Partnership with Debenhams Group
5th Jun 20267:00 amRNSFinancial Conduct Authority Update
16th Apr 20267:00 amRNSGrant of Share Options
1st Apr 202611:35 amRNSTotal Voting Rights
11th Mar 20267:00 amRNSAppointment of Nominated Adviser
2nd Mar 202611:28 amRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSTotal Voting Rights
3rd Feb 20264:05 pmRNSBLOCK LISTING SIX MONTHLY RETURN
2nd Jan 20263:48 pmRNSTotal Voting Rights
15th Dec 20256:18 pmRNSDirector/PDMR Shareholding
1st Dec 20255:43 pmRNSTotal Voting Rights
27th Nov 20253:59 pmRNSDirector/PDMR Shareholding
27th Nov 20257:00 amRNSInterim Results
26th Nov 20256:15 pmRNSRelated Party Transaction
4th Nov 20254:32 pmRNSTotal Voting Rights
1st Oct 20257:00 amRNSTotal Voting Rights
30th Sep 20259:33 amRNSResult of AGM
24th Sep 20257:00 amRNSDirectorate Change
18th Sep 20257:00 amRNSHolding(s) in Company
17th Sep 202512:30 pmRNSHolding(s) in Company
17th Sep 20257:00 amRNSDirector/PDMR Shareholding
16th Sep 20255:17 pmRNSHolding(s) in Company
16th Sep 20259:11 amRNSHolding(s) in Company
11th Sep 20254:09 pmRNSResults of General Meeting
2nd Sep 20258:30 amRNSTotal Voting Rights
1st Sep 20255:06 pmRNSHolding(s) in Company
1st Sep 20258:33 amRNSHolding(s) in Company
29th Aug 20254:50 pmRNSFinal Results, Annual Report Posting & AGM Notice
26th Aug 20257:01 amRNSCircular Publication, Notice of GM & Board Update
26th Aug 20257:00 amRNSResult of Retail Offer to existing shareholders
22nd Aug 20254:31 pmRNSPDMR Dealing
22nd Aug 20253:30 pmRNSHolding(s) in Company
22nd Aug 20258:52 amRNSHolding(s) in Company
22nd Aug 20258:40 amRNSRetail Offer to existing shareholders
22nd Aug 20258:09 amRNSResult of Placing and Subscription
22nd Aug 20257:02 amRNSProposed Placing and Subscription via ABB
22nd Aug 20257:01 amRNSPreliminary Unaudited Results
22nd Aug 20257:00 amRNSTermination of Formal Sale Process
21st Aug 202510:51 amRNSForm 8.5 (EPT/RI)
20th Aug 202510:28 amRNSForm 8.5 (EPT/RI)
19th Aug 202512:27 pmRNSFY25 Trading Update
19th Aug 202510:01 amRNSForm 8.5 (EPT/RI)
18th Aug 202510:27 amRNSForm 8.5 (EPT/RI)
15th Aug 20254:11 pmRNSHolding(s) in Company
15th Aug 20259:57 amRNSForm 8.5 (EPT/RI)
14th Aug 202510:25 amRNSForm 8.5 (EPT/RI)
13th Aug 202510:31 amRNSForm 8.5 (EPT/RI)
12th Aug 202510:05 amRNSForm 8.5 (EPT/RI)
11th Aug 202510:26 amRNSForm 8.5 (EPT/RI)
8th Aug 202511:31 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.